COTQF (Cotinga Pharmaceuticals) Days Payable : 0.00 (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Days Payable?

Cotinga Pharmaceuticals's average Accounts Payable for the three months ended in Jan. 2020 was $0.00 Mil. Cotinga Pharmaceuticals's Cost of Goods Sold for the three months ended in Jan. 2020 was $0.00 Mil.

The historical rank and industry rank for Cotinga Pharmaceuticals's Days Payable or its related term are showing as below:

COTQF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 134.39
* Ranked among companies with meaningful Days Payable only.

Cotinga Pharmaceuticals's Days Payable stayed the same from Jan. 2019 (0.00) to Jan. 2020 (0.00). stayed the same

Cotinga Pharmaceuticals Days Payable Historical Data

The historical data trend for Cotinga Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Days Payable Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Days Payable

Get a 7-Day Free Trial

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cotinga Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Days Payable falls into.

Cotinga Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cotinga Pharmaceuticals's Days Payable for the fiscal year that ended in Apr. 2019 is calculated as

	Days Payable (A: Apr. 2019 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Apr. 2018 )	+	Accounts Payable (A: Apr. 2019 ))	/	count )	/	Cost of Goods Sold (A: Apr. 2019 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Cotinga Pharmaceuticals's Days Payable for the quarter that ended in Jan. 2020 is calculated as:

	Days Payable (Q: Jan. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Oct. 2019 )	+	Accounts Payable (Q: Jan. 2020 ))	/	count )	/	Cost of Goods Sold (Q: Jan. 2020 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Cotinga Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018